Rockefeller University researchers have identified the SLC33A1 protein as a glutathione regulator that ensures proper protein folding in the endoplasmic reticulum, a discovery published in Nature Cell Biology on April 18, 2026.
The endoplasmic reticulum functions as the cell’s primary site for protein synthesis and export, requiring a precise chemical environment to prevent misfolded proteins from accumulating. For years, scientists understood that glutathione levels needed tight control in this organelle but lacked clarity on the molecular mechanism maintaining that balance.
Through a liposome-based transport assay developed by co-first authors Shanshan Liu and Mark Gad, the team visualized how SLC33A1 transports oxidized glutathione (GSSG) across the ER membrane. This selective export maintains the oxidizing environment necessary for disulfide bond formation during protein folding.
Unlike in mitochondria, where reduced glutathione predominates to support energy production and antioxidant defense, the ER depends on an oxidized glutathione ratio to enable proper folding of secretory and membrane proteins. Disruption of this balance leads to protein clogs linked to neurodegenerative disorders and certain cancers.
Birsoy’s team had previously shown that mitochondrial glutathione imbalance causes systemic failure, prompting their investigation into the ER’s distinct needs. Collaborating with Richard Hite’s lab at Memorial Sloan Kettering Cancer Center allowed them to confirm SLC33A1’s role as a glutathione exporter using cryo-EM structural data.
The regulator acts as a proofreader in the ER lumen, ensuring proteins achieve correct conformation before export to the cytosol. When SLC33A1 function falters, misfolded proteins accumulate, triggering cellular stress pathways associated with disease.
Identifying SLC33A1 as a glutathione transporter opens therapeutic avenues for neurodevelopmental disorders and cancers where ER protein-folding capacity is compromised. Inhibitors or activators of this transporter could recalibrate glutathione flux to restore folding fidelity.
Birsoy noted that Rockefeller’s longstanding ER research history made this link between glutathione regulation and disease susceptibility particularly compelling, given the organelle’s involvement in conditions ranging from Alzheimer’s to breast cancer metastasis.
The study underscores how metabolite transporters like SLC33A1 serve as critical nodes in organelle-specific redox homeostasis, extending glutathione’s known roles beyond mitochondrial function and iron regulation.
How does SLC33A1 differ from other glutathione transporters in the cell?
SLC33A1 specifically exports oxidized glutathione (GSSG) from the endoplasmic reticulum lumen to maintain an oxidizing environment for protein folding, whereas other glutathione transporters typically import reduced glutathione (GSH) into mitochondria or cytosol for antioxidant defense and metabolic support.
Why does the endoplasmic reticulum require oxidized glutathione instead of the reduced form?
The ER lumen needs an oxidizing environment to facilitate disulfide bond formation during protein folding, which stabilizes the three-dimensional structure of secretory and membrane proteins; reduced glutathione would interfere with this process by promoting a reducing atmosphere.